Signet Therapeutics (Shenzhen) Co.
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $30M
Investors
- 8
About Signet Therapeutics (Shenzhen) Co.
, Ltd. is a healthcare technology company that provides cancer innovative prescription drugs. The company is mainly involved in the field of chemical pharmacy, targeted drugs, medical, and health. The founder and CEO Dr. Haisheng Zhang graduated from Harvard University and worked at the Dana-Farber cancer institute. It has new drug research and development center in Shenzhen and Boston., Ltd. The company's main business is research and development of immune cell technology, biomedical technology, and cancer innovative prescription drugs. The company has a self-developed disease model platform that uses in the field of stomach cancer, bowel cancer, lung cancer, and breast cancer. The company’s revenue is generated by providing targeted cancer drugs.
Who invested in Signet Therapeutics (Shenzhen) Co.
8 investors across 3 rounds
See all investors in Signet Therapeutics (Shenzhen) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Signet Therapeutics (Shenzhen) Co.
Who invested in Signet Therapeutics (Shenzhen) Co.?
Signet Therapeutics (Shenzhen) Co. has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Signet Therapeutics (Shenzhen) Co. raised?
Signet Therapeutics (Shenzhen) Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Signet Therapeutics (Shenzhen) Co. last raise money?
Signet Therapeutics (Shenzhen) Co.'s most recent round on record is a Series A, in Jan 2026.
What does Signet Therapeutics (Shenzhen) Co. do?
Signet Therapeutics (Shenzhen) Co. is a biotechnology company.
Where is Signet Therapeutics (Shenzhen) Co. headquartered?
Signet Therapeutics (Shenzhen) Co. is headquartered in Shenzhen, China.
Which VCs invest in companies like Signet Therapeutics (Shenzhen) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Signet Therapeutics (Shenzhen) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Signet Therapeutics (Shenzhen) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.